Get started
Author

David Rivera de la Parra

Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study
2020 · David Adams, Michael Polydefkis, et al. · The Lancet Neurology · 159
Five-Year Results With Patisiran for Hereditary Transthyretin Amyloidosis With Polyneuropathy
2025 · David Adams, Jonas Wixner, et al. · JAMA Neurology · 40
PDF
Factors Associated with Insulin Nonadherence in Type 1 Diabetes Mellitus Patients in Mexico
2019 · Paloma Almeda-Valdes, Josefa Palacio Ríofrio, et al. · Dubai Diabetes and Endocrinology Journal · 14
A case study on the implementation of quality and comprehensive indicators set in routine diabetes care
2024 · Ana Cristina García-Ulloa, José Luis Cárdenas-Fragoso, et al. · Archives of Public Health · 2
PDF
Description of the Glycemic Control Metrics Evaluated by Glucose Monitoring in a Cohort of Adult Patients Hospitalized With Hyperglycemia and Diagnosis of Covid 19
2021 · Arnaldo Medina, Diana Cristina Henao, et al. · Diabetes Technology & Therapeutics · 2
Development and Validation of a Software Linked to an Internet Portal That Facilitates the Medical Treatment and Empowerment of Patients with Type 2 Diabetes, Interaction with Medical Personnel, and the Generation of a Real-Time Registry
2020 · Ana Cristina García-Ulloa, Paloma Almeda-Valdes, et al. · Journal of Diabetes Science and Technology · 2
Works count: 6
Citation count: 219
H-index: 3
I10-index: 3
Year
Topic
Type